Securian Asset Management Inc. Sells 344 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Securian Asset Management Inc. trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,634 shares of the company’s stock after selling 344 shares during the quarter. Securian Asset Management Inc.’s holdings in Henry Schein were worth $459,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. Sequoia Financial Advisors LLC increased its holdings in Henry Schein by 7.2% in the fourth quarter. Sequoia Financial Advisors LLC now owns 6,109 shares of the company’s stock valued at $423,000 after purchasing an additional 412 shares during the period. HighTower Advisors LLC grew its position in shares of Henry Schein by 242.9% in the 4th quarter. HighTower Advisors LLC now owns 43,347 shares of the company’s stock valued at $3,000,000 after buying an additional 30,706 shares during the last quarter. AGF Management Ltd. acquired a new stake in shares of Henry Schein in the fourth quarter valued at about $796,000. Daiwa Securities Group Inc. increased its stake in shares of Henry Schein by 5.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 16,486 shares of the company’s stock valued at $1,141,000 after buying an additional 850 shares during the period. Finally, Isthmus Partners LLC raised its position in shares of Henry Schein by 2.8% during the fourth quarter. Isthmus Partners LLC now owns 9,888 shares of the company’s stock worth $684,000 after acquiring an additional 266 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Trading Up 1.7 %

HSIC stock opened at $71.80 on Tuesday. The company has a market capitalization of $8.92 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business has a 50 day simple moving average of $74.84 and a two-hundred day simple moving average of $72.62.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.66 EPS. Research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HSIC shares. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.